Literature DB >> 8504303

Fucosidosis: four new mutations and a new polymorphism.

H C Seo1, P J Willems, K A Kretz, B M Martin, J S O'Brien.   

Abstract

Fucosidosis is a rare lysosomal storage disease due to a nearly complete deficiency of alpha-L-fucosidase (EC 3.2.1.51). In this study, all 8 exons of the alpha-L-fucosidase structural gene (FUCA-1) were amplified by PCR methods, and the amplified products were subcloned and sequenced. Five patient groups with fucosidosis were selected according to their ethnic backgrounds and haplotypes for RFLPs in FUCA-1. Four presumptive disease causing mutations were detected: 1) A major deletion of DNA containing the last two exons of FUCA-1 in two Algerian siblings. 2) A G to T mutation in exon 6 resulting in an in-frame termination codon (E375X) in eight Hispanic patients from Colorado and New Mexico. 3) A G to A mutation (G60D) in exon 1 in four Italian patients and in three related French-American (Cajun) patients. This G60D mutation creates a unique site for AflIII. 4) A frameshift mutation resulted from a two-base deletion in exon 2 (K151fs) in an Italian patient. This deletion obliterates a unique BstXI site and creates a new BpmI site, and was found in only this patient and in only one allele. The rationale for proposing these defects as disease causing mutations includes pedigree analysis and the predicted consequences of each defect upon the activity and the concentration of the enzyme. An A to G transition (Q281R) in exon 5 was found to be present in homozygous form in affected patients and also in normal subjects; it appears to be a newly identified polymorphism. It causes a charge change and may be responsible for the electrophoretic variant phenotype of fucosidosis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8504303     DOI: 10.1093/hmg/2.4.423

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  9 in total

1.  Fucosidosis: genetic and biochemical analysis of eight cases.

Authors:  H Cragg; M Williamson; E Young; J O'Brien; J Alhadeff; S Fang-Kircher; E Paschke; B Winchester
Journal:  J Med Genet       Date:  1997-02       Impact factor: 6.318

2.  Purification and characterization of alpha-L-fucosidase from human primary hepatocarcinoma tissue.

Authors:  Chao Li; Jie Qian; Ju-Sheng Lin
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

3.  A Gln-281 to Arg substitution in alpha-L-fucosidase is responsible for a common polymorphism detected by isoelectric focusing.

Authors:  M Yang; R A DiCioccio
Journal:  Hum Genet       Date:  1994-05       Impact factor: 4.132

4.  Molecular basis of the common electrophoretic polymorphism (Fu1/Fu2) in human alpha-L-fucosidase.

Authors:  H Cragg; B Winchester; H C Seo; J O'Brien; D Swallow
Journal:  J Med Genet       Date:  1994-08       Impact factor: 6.318

5.  Isolation of the canine alpha-L-fucosidase cDNA and definition of the fucosidosis mutation in English Springer Spaniels.

Authors:  T Occhiodoro; D S Anson
Journal:  Mamm Genome       Date:  1996-04       Impact factor: 2.957

6.  Cryo-EM structures of human fucosidase FucA1 reveal insight into substrate recognition and catalysis.

Authors:  Zachary Armstrong; Richard W Meek; Liang Wu; James N Blaza; Gideon J Davies
Journal:  Structure       Date:  2022-07-29       Impact factor: 5.871

7.  Mutation identification and characterization of a Taiwanese patient with fucosidosis.

Authors:  Shuan-Pei Lin; Jui-Hung Chang; Maria Paez de la Cadena; Ting-Fang Chang; Guey-Jen Lee-Chen
Journal:  J Hum Genet       Date:  2007-04-11       Impact factor: 3.172

8.  The molecular defect underlying canine fucosidosis.

Authors:  B J Skelly; D R Sargan; M E Herrtage; B G Winchester
Journal:  J Med Genet       Date:  1996-04       Impact factor: 6.318

Review 9.  Fucosidosis-Clinical Manifestation, Long-Term Outcomes, and Genetic Profile-Review and Case Series.

Authors:  Karolina M Stepien; Elżbieta Ciara; Aleksandra Jezela-Stanek
Journal:  Genes (Basel)       Date:  2020-11-22       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.